Commonwealth Equity Services’s Columbia Research Enhanced Value ETF REVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.17M Buy
40,831
+16,043
+65% +$467K ﹤0.01% 2480
2025
Q4
$701K Buy
24,788
+3,191
+15% +$90.1K ﹤0.01% 2877
2025
Q3
$604K Buy
21,597
+11,063
+105% +$301K ﹤0.01% 3024
2025
Q2
$277K Buy
10,534
+570
+6% +$14.1K ﹤0.01% 3668
2025
Q1
$251K Buy
9,964
+1,715
+21% +$43.6K ﹤0.01% 3647
2024
Q4
$204K Buy
+8,249
New +$213K ﹤0.01% 3744

Other funds holding REVS

Commonwealth Equity Services's REVS Position: Q1 2026 in Review

Commonwealth Equity Services increased its Columbia Research Enhanced Value ETF (REVS) stake by 65% in Q1 2026, buying an estimated $467K and bringing the position to 40,831 shares worth $1.17M. The position accounts for ﹤0.01% of the portfolio, ranked #2480.

Commonwealth Equity Services first reported a position in REVS in Q4 2024 and has held it in 6 quarters since. 37 funds tracked by Wall St. Rank hold REVS as of Q1 2026.

  • Commonwealth Equity Services held 40,831 shares of Columbia Research Enhanced Value ETF worth $1.17M as of Q1 2026.
  • Commonwealth Equity Services bought 16,043 Columbia Research Enhanced Value ETF shares in Q1 2026, an estimated $467K.
  • Columbia Research Enhanced Value ETF made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q1 2026, its #2480 holding.
  • Commonwealth Equity Services first reported a position in Columbia Research Enhanced Value ETF in Q4 2024 and has held it in 6 quarters since.
  • 37 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q1 2026.

Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.